It has been documented that TLRs could activate ADAM17 leading to tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6) and epidermal growth factor receptor (EGFR) after viral infection [14,30]. This evidence concerns the gene TNF and viral infectious disease.